Alzheimer's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Alzheimer's Disease, including details on diagnosis, memory loss, heredity, treatment, medication.

Volume 5 (2008), Issue 3 (March)

1. Does oxybutynin alter plaques, amyloid beta peptides and behavior in a mouse model of Alzheimer's disease?
   J Urol, 179(3): 1173-7. [Abstract] [Full-text]
2. A 74-year-old man with memory loss and neuropathy who enjoys alcoholic beverages.
   JAMA, 299(9): 1046-54. [Abstract] [Full-text]
3. Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging.
   Neurobiol Aging, 29(4): 514-23. [Abstract] [Full-text]
4. Mutations enhance the aggregation propensity of the Alzheimer's A beta peptide.
   J Mol Biol, 377(2): 565-74. [Abstract] [Full-text]
5. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
   Pharmacogenet Genomics, 18(4): 289-98. [Abstract] [Full-text]
6. Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer's disease.
   Int J Exp Pathol, 89(2): 81-90. [Abstract] [Full-text]
7. Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons.
   Proc Natl Acad Sci U S A, 105(11): 4441-6. [Abstract] [Full-text]
8. DSCR1/RCAN1 regulates vesicle exocytosis and fusion pore kinetics: implications for Down syndrome and Alzheimer's disease.
   Hum Mol Genet, 17(7): 1020-30. [Abstract] [Full-text]
9. Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer's disease.
   Hum Mol Genet, 17(7): 929-35. [Abstract] [Full-text]
10. Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2.
    J Neurosci, 28(12): 3051-9. [Abstract] [Full-text]
11. Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort.
    Neurology, 70(13): 1042-8. [Abstract] [Full-text]
12. Misclassified tissue volumes in Alzheimer disease patients with white matter hyperintensities: importance of lesion segmentation procedures for volumetric analysis.
    Stroke, 39(4): 1134-41. [Abstract] [Full-text]
13. Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging.
    Stroke, 39(4): 1127-33. [Abstract] [Full-text]
14. Increased intraneuronal resting [Ca2+] in adult Alzheimer's disease mice.
    J Neurochem, 105(1): 262-71. [Abstract] [Full-text]
15. CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease.
    Neurobiol Aging, 29(5): 669-75. [Abstract] [Full-text]
16. Olfaction in patients with mild cognitive impairment and Alzheimer's disease.
    Neurobiol Aging, 29(5): 693-706. [Abstract] [Full-text]
17. Lack of association of hepatic lipase polymorphisms with late-onset Alzheimer's disease.
    Neurobiol Aging, 29(5): 793-4. [Abstract] [Full-text]
18. Platelet beta-secretase activity is increased in Alzheimer's disease.
    Neurobiol Aging, 29(5): 661-8. [Abstract] [Full-text]
19. Characterization of fibrillation process of alpha-synuclein at the initial stage.
    Biochem Biophys Res Commun, 369(3): 910-4. [Abstract] [Full-text]

© 2004-2008 Alzheimer's Disease Research Today. All Rights Reserved.